Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Nimbus Therapeutics
3162
Nimbus Therapeutics
Technology
Biotechnology
Health Care
Medical
Therapeutics
Biotech company harnessing the power of computational chemistry to design breakthroughs for serious, underserved diseases.
Suggest edits
Type
B2c
Founded
2009
Raised
$89M
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Xconomy
Biogen
Money Mover
HubSpot
Formlabs
Akamai
General Catalyst
Companies in the same industry
Immunai
Stemson Therapeutics
Neuronetics, Inc.
Pear Therapeutics
MATINAS BIOPHARMA
Neos Therapeutics, Inc.
FLX Bio, Inc.
Marina Biotech
SyntheX
Cedilla Therapeutics
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Latest funding
$65,000,000
Venture capital (Series C) - 2018
Atlas Venture
SR One
Lilly Ventures
+4
$24,000,000
Venture capital (Series A) - 2011
Team Size
1–10
Employees
I work here
Location
Cambridge
,
United States
Headquarters
Explore Cambridge
$65,000,000
Venture capital (Series C)
FinSMEs
,
PE HUB
Biotech Company Nimbus Therapeutics Secures $65M in Funding
Funding
